More Than Pink Episodes

Dr. Dawn Hershman, Columbia University Medical Center, Komen Scholar Dawn Hershman is a tenured professor of medicine and epidemiology at Columbia University, where she leads their breast cancer program, and a nationally recognized expert in breast cancer treatment, prevention, and survivorship. She is also a Komen Scholar. In this episode, Hershman discusses the different struggles…

Marla Blaylock, Komen Austin Board Member, Survivor Marla Blaylock is the CEO and Founder of Blue Lotus Systems. BLS is an established Austin based full-service IT Services provider with 14 years of history, that brings together world-class experts in strategic IT disciplines. She is also a Komen Austin board member and a breast cancer survivor.…

Wendy Y. Chen MD, MPH, Senior Physician, Breast Oncology Center Dana Farber Cancer Institute. Faculty member, Harvard Medical School Biosimilar pharmalogics are made from living organisms and offer a new and exciting way to treat breast cancer which can be less expensive, have fewer side effects and replicate the results of their chemical based counterparts.…

Keith L. Knutson is the Director of the Discovery and Translation Lab’s Cancer Research Program and a Ph.D., Consultant in the Department of Immunology, Mayo Clinic, Florida. We are getting more and more sophisticated in determining the types of breast cancer tumors and how they act in the body. Dr. Knutson and his team at…

Today’s guest is Dr. Joseph Sparano, Professor of Medicine & Obstetrics, Gynecology, and Women’s Health, Albert Einstein College of Medicine. Chemotherapy has been a gold standard for treatment of breast cancer and often over-treats women who may not need this aggressive treatment to treat their breast cancer. Dr. Sparano serves as the study chair for…

Dr. Tom Yankeelov,W. A. “Tex” Moncrief, Jr. Chair in Computational Engineering and Sciences IV – Computational Oncology The overall goal of Dr. Thomas Yankeelov’s clinical research is to improve patient care by employing advanced imaging methods for the early identification, assessment, and prediction of tumors’ response to therapy. He develops tumor forecasting methods by integrating…

As a breast imaging doctor, Dr. Elizabeth Morris interprets radiology images such as mammography (including 3D tomosynthesis and contrast-enhanced mammography), breast ultrasound, and breast MRI (including abbreviated MRI). She also does breast biopsies with imaging guidance. She and her team have pioneered high-risk screening with MRI and offer personalized screening to women with average risk…

Dr. Brugge is currently Director of the Ludwig Center at Harvard Medical School. Dr. Brugge has held full professorships at the State University of New York, Stony Brook, and the University of Pennsylvania, where she was named also named as an investigator at the Howard Hughes Medical Institute. From 1992-1997, Dr. Brugge was Scientific Director…

Dr. Lee is Professor of Pharmacology and Chemical Biology, and Professor of Human Genetics at the University of Pittsburgh. He is also the Pittsburgh Foundation Chair in Precision Medicine. Lee received his B.Sc. and PhD in England, and came to San Antonio for his postdoctoral studies. He was subsequently recruited to Baylor College of Medicine…

Dr. Vineet Choudhry, MD is a general surgery specialist in Austin, TX and has been practicing for 10 years. He graduated from The Texas A&M University System Health Science Center College Of Medicine in 2003 and specializes in general surgery. Dr. Choudhry and Suzanne discuss clinical trials, specifically cryoblation treatment. “Breast cancer is a very…